Although AMPK activation is neuroprotective in PD and Metformin induces direct protective effects through AMPK in other disease states such stroke [47], our studies show that Metformin doesn’t activate AMPK in dopamine neurons to prevent degeneration in a mouse model of PD. Here, PRKAB1 is linked to Parkinson disease.